Gastric Cancer Risk (Pre-disease) Classification Chip
This product is the research-grade microarray (biochip), featuring 40 selected capturing peptides (discovered by HiPep) focusing on precancerous gastric lesions (such as atrophic gastritis and intestinal metaplasia) arrayed on amorphous carbon substrates. Minute samples of gastric fluid are required to assess the risk of progression to gastric cancer without pathological tissue biopsies. PepTenCam is a suitable detector, although measurements can also be performed with your in-house fluorescence detectors and/or scanners.
2026.05.29